Gardiner will oversee talent acquisition and HR operations during period of rapid company growth VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, today… Read More
Pravibismane is the first of a new class of drugs with broad-spectrum potency against a wide range of pathogens, including NTM species Poster presentation highlighted the results from pravibismane in… Read More
OTTAWA, ON | Health Canada Today, the Honourable Mark Holland, Minister of Health, announced a new appointment to the Patented Medicine Prices Review Board (PMPRB). Following a merit-based selection process,… Read More
Nimbus Synergies, a leading Canadian early-stage health technology investor and mentor to Canada’s most promising health tech entrepreneurs, is excited to announce the GENERATOR’s relocation to new office space situated… Read More
Poster presentation describes Phase 2 study assessing safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers Phase 2 study is funded,… Read More
